# Phosphodiesterase-5-inhibitors for Right Heart Failure After Left Ventricular Assist Device Implantation

> **NCT04117659** · NA · COMPLETED · sponsor: **University Hospital, Essen** · enrollment: 32 (actual)

## Conditions studied

- Phosphodiesterase Inhibitor Adverse Reaction
- Right-Sided Heart Failure

## Interventions

- **OTHER:** withdrawal of oral medication (phosphodiesterase-5 inhibitor) in pretreated patients

## Key facts

- **NCT ID:** NCT04117659
- **Lead sponsor:** University Hospital, Essen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-15
- **Primary completion:** 2021-02-26
- **Final completion:** 2021-03-15
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2022-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04117659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04117659, "Phosphodiesterase-5-inhibitors for Right Heart Failure After Left Ventricular Assist Device Implantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04117659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*